Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse
This study has been completed.
Palo Alto Medical Foundation
Information provided by:
NIH AIDS Clinical Trials Information Service
First received: November 2, 1999
Last updated: June 23, 2005
Last verified: June 1989
To compare pyrimethamine and intravenous (IV) clindamycin vs. pyrimethamine and sulfonamides in the treatment of AIDS patients with central nervous system (CNS) Toxoplasma gondii.
|Study Design:||Primary Purpose: Treatment|
|Official Title:||Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse|
Resource links provided by NLM:
Drug Information available for: Pyrimethamine Clindamycin Clindamycin hydrochloride Clindamycin phosphate Clindamycin palmitate hydrochloride Clindamycin palmitateU.S. FDA Resources
Further study details as provided by NIH AIDS Clinical Trials Information Service:
Contacts and Locations